Skip to main content

Advertisement

SpringerLink
Log in

Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Aim

Pharmacogenetics holds the potential to elucidate the inherited basis of differences between individual responses to drugs. Impacts of CYP3A5 and ABCB1 gene polymorphisms on the immunosuppressant tacrolimus have been reported in previous studies of liver transplantation. The functions of interleukin-10 (IL-10) gene expression are complex in the early period after liver transplantation. In this study, we examined the IL-10 genotypes of both recipients and donors to clarify the influence of these genetic variants on tacrolimus dose requirements and pharmacokinetics.

Methods

Genetic polymorphisms of IL-10, CYP3A5, and ABCB1 were evaluated for 53 liver transplant recipients and 53 donors. Tacrolimus doses and blood concentrations were determined at 1, 2, and 3 weeks, and 1 month after transplantation. IL-10 polymorphisms at G-1082A, C-819 T, and C-592A; CYP3A5 polymorphisms at A6986G; and ABCB1 polymorphisms at C1236T, G2677T, and C3435T were assessed by PCR amplification and DNA sequencing.

Results

Recipients who received organs from CYP3A5*3/*3 donors had higher tacrolimus C/D ratios. In the first 2 weeks, the tacrolimus C/D ratios of the recipients with donors who were CYP3A5 nonexpressors and had a low IL-10 production genotype (-819TT, -592 AA) were higher than those with donors who were CYP3A5 nonexpressors and had a high IL-10 production genotype (-819CC or CT, -592CC or AC). There were no significant differences in laboratory data or clinical characteristics (which could influence the tacrolimus C/D ratio) between the two groups of patients (P > 0.05).

Conclusion

Determining IL-10 and CYP3A5 polymorphisms of donors may allow individualized tacrolimus dosage regimens to be determined for liver transplant patients during the early posttransplantation period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

CYP3A5:

Cytochrome P450

ABCB1:

ATP-binding cassette subfamily B, member 1

IL-10:

Interleukin-10

References

  1. Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Okuda M, Tanaka K, Inui K (2004) CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation. Pharmacogenetics 14:471

    Article  PubMed  CAS  Google Scholar 

  2. Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, Sheng Y (2006) Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transplant 12:775

    Article  Google Scholar 

  3. Uesugi M, Masuda S, Katsura T, Oike F, Takada Y, Inui K (2006) Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. Pharmacogenet Genomics 16:119

    Article  PubMed  CAS  Google Scholar 

  4. Yu S, Wu L, Jin J, Yan S, Jiang G, Xie H, Zheng S (2006) Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation 81:46–51

    Article  PubMed  CAS  Google Scholar 

  5. Staatz CE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I. Clin Pharmacokinet 49:141–175

    Article  PubMed  CAS  Google Scholar 

  6. Zhang X, Liu Z, Zheng JM, Tang Z, Chen JS, Li LS (2005) Influence of CYP3A5 and MDRl polymorphisms on tacrolimus concentration in the early stage after renal transplantation. Clin Transplant 19:638–643

    Article  PubMed  Google Scholar 

  7. Wang WL, Jin J, Zheng SS, Wu LH, Liang TB, Yu SF, Yan S (2006) Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transplant 12:775–780

    Article  Google Scholar 

  8. Wang J, Zeevi A, McCurry K, Schuetz E, Zheng H, Iacono A, McDade K, Zaldonis D, Webber S, Watanabe RM, Burckart GJ (2006) Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors. Transpl Immunol 15:235–240

    Article  PubMed  Google Scholar 

  9. Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B (2000) In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther 67:32–43

    Article  PubMed  CAS  Google Scholar 

  10. Li D, Zhu JY, Gao J, Wang X, Lou YQ, Zhang GL (2007) Polymorphisms of tumour necrosis factor-a, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus. Clin Chim Acta 383:133–139

    Article  PubMed  CAS  Google Scholar 

  11. Haufroid V, Wallemacq P, VanKerckhove V, Elens L, De Meyer M, Eddour DC, Malaise J, Lison D, Mourad M (2006) CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant 6:2706

    Article  PubMed  CAS  Google Scholar 

  12. Mourad M, Mourad G, Wallemacq P, Garrigue V, Van Bellingen C, Van Kerckhove V, De Meyer M, Malaise J, Eddour DC, Lison D, Squifflet JP, Haufroid V (2005) Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1polymorphisms and steroids. Transplantation 80:977

    Article  PubMed  CAS  Google Scholar 

  13. Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B (2003) Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 14:1889–1896

    Article  PubMed  CAS  Google Scholar 

  14. Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Bowman P (2003) Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 3:477–483

    Article  PubMed  CAS  Google Scholar 

  15. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170–181

    Article  PubMed  CAS  Google Scholar 

  16. Kabay B, Kocaefe C, Baykal A, Ozden H, Baycu C, Oner Z, Ozgüç M, Sayek I (2007) Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis. World J Surg 31:105–115

    Article  PubMed  Google Scholar 

  17. Lan L, Chen Y, Sun C, Sun Q, Hu J, Li D (2008) Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int 21(6):581–592

    Article  PubMed  CAS  Google Scholar 

  18. Döll S, Schrickx JA, Dänicke S, Fink-Gremmels J (2009) Interactions of deoxynivalenol and lipopolysaccharides on cytokine excretion and mRNA expression in porcine hepatocytes and Kupffer cell enriched hepatocyte cultures. Toxicol Lett 190:96–105

    Article  PubMed  Google Scholar 

  19. Chen YX, Huang YH, Chen ZX, Zheng WD, Wang XZ (2008) Construction of eukaryotic expression plasmid containing rat interleukin-10 gene and its expression in BRL cells in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24:332–334

    PubMed  Google Scholar 

  20. Warlé MC, Metselaar HJ, Hop WC, Tilanus HW (2005) Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis. Liver Transpl 11:19–26

    Article  PubMed  Google Scholar 

  21. Girnita DM, Burckart G, Zeevi A (2008) Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol 20:614–625

    Article  PubMed  CAS  Google Scholar 

  22. Warlé MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, de Rave S, Kwekkeboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ (2002) Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 8:603–611

    Article  PubMed  Google Scholar 

  23. Wang J (2009) CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation. Expert Rev Mol Diagn 9:383–390

    Article  PubMed  CAS  Google Scholar 

  24. Lee CM, Pohl J, Morgan ET (2009) Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab Dispos 37:865–872

    Article  PubMed  CAS  Google Scholar 

  25. Liptrott NJ, Penny M, Bray PG, Sathish J, Khoo SH, Back DJ, Owen A (2009) The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br J Pharmacol 156:497–508

    Article  PubMed  CAS  Google Scholar 

  26. Bertilsson PM, Olsson P, Magnusson KE (2001) Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. J Pharm Sci 90:638–646

    Article  PubMed  CAS  Google Scholar 

  27. Lodewijk L, Mall A, Spearman CW, Kahn D (2009) Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. Transplant Proc 41:379–381

    Article  PubMed  CAS  Google Scholar 

  28. Haas CE, Kaufman DC, Jones CE, Burstein AH, Reiss W (2003) Cytochrome P450 3A4 activity after surgical stress. Crit Care Med 31:1338–1346

    Article  PubMed  CAS  Google Scholar 

  29. Iñiguez M, Dotor J, Feijoo E, Goñi S, Prieto J, Berasain C, Avila MA (2008) Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury. Recent Pat Cardiovasc Drug Discov 3:9–18

    Article  PubMed  Google Scholar 

  30. Zhu J, Wang S, Bie P, Li X, Zhang Y, Xiong Y, Wang H, Ma Z, Li K, Dong J (2007) Apoptosis and regeneration of sinusoidal endothelial cells after extended cold preservation and transplantation of rat liver. Transplantation 84:1483–1491

    Article  PubMed  Google Scholar 

  31. Favre C, Monti JA, Scapini C, Pellegrino J, Carnovale CE, Carrillo MC (1998) Putrescine decreases cytochrome P450 3A4 levels during liver regeneration in the rat. J Hepatol 28:700–708

    Article  PubMed  CAS  Google Scholar 

  32. Dinant S, Veteläinen RL, Florquin S, van Vliet AK, van Gulik TM (2007) IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 141:176–182

    Article  PubMed  CAS  Google Scholar 

  33. Lan L, Chen YW, Sun C, Liu BW, Sun QL, Li DG (2009) Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats. Zhonghua Gan Zang Bing Za Zhi 17:915–920

    PubMed  CAS  Google Scholar 

  34. Golling M, Sadeghi M, Zipperle S, Fonouni H, Golriz M, Mehrabi A (2009) In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. Clin Transplant 23 (Suppl 21):83–91

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Leading Project of Science and Technology Commission of Shanghai Municipality (074119605); the Program for Outstanding Medical Academic Leader of Shanghai Municipality (LJ06024); and National Key Technology R&D Program in the 11th Five Year Plan of China (2008BAI60B03).

Author information

Authors and Affiliations

  1. Department of Pharmacy, Shanghai First People’s Hospital, Shanghai Jiaotong University, Shanghai, 200080, China

    Xiaoqing Zhang & Gaolin Liu

  2. Department of Hepatobiliary Pancreatic Surgery, Shanghai First People’s Hospital, Shanghai Jiaotong University, Shanghai, 200080, China

    Zhaowen Wang, Junwei Fan & Zhihai Peng

  3. Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China

    Xiaoqing Zhang

Authors
  1. Xiaoqing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaowen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junwei Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gaolin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhihai Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Gaolin Liu or Zhihai Peng.

Additional information

Zhang Xiaoqing and Wang Zhaowen contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X., Wang, Z., Fan, J. et al. Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period. Eur J Clin Pharmacol 67, 803–813 (2011). https://doi.org/10.1007/s00228-011-0993-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-0993-8

Keywords

Search

Navigation